Risk Factors for Mortality Among COVID-19 Patients

Overview

Journal Diabetes Res Clin Pract

Specialty Endocrinology

Date 2020 Jul 6

PMID 32623035

Citations 98

Authors

Orwa Albitar

Rama Ballouze

Jer Ping Ooi

Siti Maisharah Sheikh Ghadzi

Affiliations

Soon will be listed here.

Abstract

Aims: COVID-19 is a current global pandemic. However, comprehensive global data analyses for its mortality risk factors are lacking. The current investigation aimed to assess the predictors of death among COVID-19 patients from worldwide open access data.

Methods: A total of 828 confirmed cases of COVID-19 with definite outcomes were retrospectively identified from open access individual-level worldwide data. Univariate followed by multivariable regression analysis were used to evaluate the association between potential risk factors and mortality.

Results: Majority of the patients were males 59.1% located in Asia 69.3%. Based on the data, older age (adjusted odds ratio (aOR), 1.079; 95% confidence intervals (95% CI), 1.064-1.095 per year increase), males (aOR, 1.607; 95% CI, 1.002-2.576), patients with hypertension (aOR, 3.576; 95% CI, 1.694-7.548), diabetes mellitus (aOR, 12.234; 95% CI, 4.126-36.272), and patients located in America (aOR, 7.441; 95% CI, 3.546-15.617) were identified as the risk factors of mortality among COVID-19 patients.

Conclusions: Males, advanced age, hypertension patients, diabetes mellitus patients, and patients located in America were the independent risk factors of death among COVID-19 patients. Extra attention is required to be given to these factors and additional studies on the underlying mechanisms of these effects.

Citing Articles

Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort.

Ndagijimana F, Park T Genomics Inform. 2025; 23(1):2.

PMID: 39891219 PMC: 11786383. DOI: 10.1186/s44342-024-00035-y.

Comparison of Emergency Department Disposition Times in Adult Level I and Level II Trauma Centers.

Lane S, Nahmias J, Lekawa M, Fox J, Chandwani C, Lotfipour S West J Emerg Med. 2024; 25(6):938-945.

PMID: 39625767 PMC: 11610736. DOI: 10.5811/westjem.20523.

Cross-Section of Neurological Manifestations Among SARS-CoV-2 Omicron Subvariants-Single-Center Study.

Jachman-Kapulka J, Zinczuk A, Simon K, Rorat M Brain Sci. 2024; 14(11).

PMID: 39595924 PMC: 11591697. DOI: 10.3390/brainsci14111161.

The effectiveness of COVID-19 vaccination in preventing hospitalisation and mortality: A nationwide cross-sectional study in Iran.

Razimoghadam M, Daroudi R, Yaseri M J Glob Health. 2024; 14:05026.

PMID: 39325919 PMC: 11426934. DOI: 10.7189/jogh.14.05026.

Application of type II diabetes incidence and mortality rates for insurance.

Yue J, Wang H, Chang T PLoS One. 2024; 19(9):e0307508.

PMID: 39321149 PMC: 11423961. DOI: 10.1371/journal.pone.0307508.

References

Alqahtani J, Oyelade T, Aldhahir A, Alghamdi S, Almehmadi M, Alqahtani A . Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020; 15(5):e0233147. PMC: 7213702. DOI: 10.1371/journal.pone.0233147. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Wenham C, Smith J, Morgan R . COVID-19: the gendered impacts of the outbreak. Lancet. 2020; 395(10227):846-848. PMC: 7124625. DOI: 10.1016/S0140-6736(20)30526-2. View

Chu C, Poon L, Cheng V, Chan K, Hung I, Wong M . Initial viral load and the outcomes of SARS. CMAJ. 2004; 171(11):1349-52. PMC: 527336. DOI: 10.1503/cmaj.1040398. View

Hong K, Choi J, Hong S, Lee J, Kwon J, Kim S . Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2017; 73(3):286-289. DOI: 10.1136/thoraxjnl-2016-209313. View

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368:m1091. PMC: 7190011. DOI: 10.1136/bmj.m1091. View

Peng Y, Meng K, Guan H, Leng L, Zhu R, Wang B . [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48(6):450-455. DOI: 10.3760/cma.j.cn112148-20200220-00105. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Pareek M, Bangash M, Pareek N, Pan D, Sze S, Minhas J . Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020; 395(10234):1421-1422. PMC: 7173801. DOI: 10.1016/S0140-6736(20)30922-3. View

10.

To K, Tsang O, Leung W, Tam A, Wu T, Lung D . Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; 20(5):565-574. PMC: 7158907. DOI: 10.1016/S1473-3099(20)30196-1. View

11.

. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(12):343-346. PMC: 7725513. DOI: 10.15585/mmwr.mm6912e2. View

12.

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

13.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

14.

Opal S, Girard T, Wesley Ely E . The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005; 41 Suppl 7:S504-12. DOI: 10.1086/432007. View

15.

Fang Y, Nie Y, Penny M . Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis. J Med Virol. 2020; 92(6):645-659. PMC: 7228381. DOI: 10.1002/jmv.25750. View

16.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

17.

Ruocco G, Feola M, Palazzuoli A . Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity. Int J Infect Dis. 2020; 95:373-375. PMC: 7180155. DOI: 10.1016/j.ijid.2020.04.058. View

18.

Pal R, Bhansali A . COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract. 2020; 162:108132. PMC: 7118535. DOI: 10.1016/j.diabres.2020.108132. View

19.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View

20.

Ji W, Wang W, Zhao X, Zai J, Li X . Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020; 92(4):433-440. PMC: 7138088. DOI: 10.1002/jmv.25682. View